Merck Sharp & Dohme Corp

Where the EU money came from

Funding by EU programme. Amounts are Merck Sharp & Dohme Corp's own share of each project, not the project's full budget.

Projects

23 EU-funded projects, newest first. Each links to the official record.

• FORTIFYPartner

  FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE

  Horizon Europe · 2026–2029 · Project on CORDIS ↗
• BRIDGEPartner

  Breakthrough Regulatory Innovation and Development throuGh sandbox Environments

  Horizon Europe · 2025–2028 · Project on CORDIS ↗
• PREMIERPartner

  Prioritisation and Risk Evaluation of Medicines in the EnviRonment

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗
• PharmaLedgerPartner

  PharmaLedger

  Horizon 2020 · 2020–2022 · Project on CORDIS ↗
• imSAVARPartner

  Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

  Horizon 2020 · 2019–2025 · Project on CORDIS ↗
• NeuroDeRiskPartner

  Neurotoxicity De-Risking in Preclinical Drug Discovery

  Horizon 2020 · 2019–2022 · Project on CORDIS ↗
• TransBioLinePartner

  Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

  Horizon 2020 · 2019–2025 · Project on CORDIS ↗
• VITALPartner

  Vaccines and Infectious Diseases in the Ageing PopuLation

  Horizon 2020 · 2019–2024 · Project on CORDIS ↗
• PARADIGMPartner

  Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

  Horizon 2020 · 2018–2020 · Project on CORDIS ↗
• DO-ITPartner

  Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

  Horizon 2020 · 2017–2019 · Project on CORDIS ↗
• IB4SD-TRISTANPartner

  Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

  Horizon 2020 · 2017–2024 · Project on CORDIS ↗
• PREFERPartner

  Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

  Horizon 2020 · 2016–2022 · Project on CORDIS ↗
• VSV-EBOPLUSPartner

  SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068

  Horizon 2020 · 2016–2023 · Project on CORDIS ↗
• ADAPT-SMARTPartner

  Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

  Horizon 2020 · 2015–2018 · Project on CORDIS ↗
• IPIEPartner

  Intelligent Assessment of Pharmaceutical in the Environment

  FP7 (2007 to 2013) · 2015–2019 · Project on CORDIS ↗
• EPADPartner

  European Prevention of Alzheimer’s Dementia Consortium

  FP7 (2007 to 2013) · 2015–2019 · Project on CORDIS ↗
• DRIVE-ABPartner

  DRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE

  FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗
• GETREALPartner

  Incorporating real-life clinical data into drug development

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
• ADVANCEPartner

  Accelerated Development of Vaccine benefit-risk Collaboration in Europe

  FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗
• ORBITOPartner

  Oral biopharmaceutics tools

  FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
• EUPATIPartner

  European Patients' Academy on Therapeutic Innovation

  FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
• RAPP-IDPartner

  Development of RApid Point-of-Care test Platforms for Infectious Diseases

  FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
• U-BIOPREDPartner

  Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes

  FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Novartis Pharma AGSwitzerland · 18 shared projects
• Pfizer LimitedUnited Kingdom · 17 shared projects
• Janssen Pharmaceutica NVBelgium · 15 shared projects
• F. Hoffmann-La Roche AGSwitzerland · 15 shared projects
• Sanofi-Aventis Recherche & DeveloppementFrance · 15 shared projects
• Glaxosmithkline Research & Development LimitedUnited Kingdom · 14 shared projects
• Astrazeneca ABSweden · 11 shared projects
• Eli Lilly and Company LtdUnited Kingdom · 11 shared projects
• Boehringer Ingelheim InternationalgmbhGermany · 11 shared projects
• Bayer AktiengesellschaftGermany · 9 shared projects
• Novo Nordisk A/SDenmark · 9 shared projects
• Merck Kommanditgesellschaft Auf AktienGermany · 8 shared projects
• Ucb BiopharmaBelgium · 8 shared projects
• AmgenBelgium · 6 shared projects
• Katholieke Universiteit LeuvenBelgium · 5 shared projects
• Stichting Radboud UniversiteitNetherlands · 5 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• alzheimer
• antibiotic resistance
• antibiotics
• asthma
• big data
• business intelligence
• business models
• clinical medicine
• coronaviruses
• cryptography
• data processing
• databases
• drug discovery
• drug safety